David R. Stevens - 30 Dec 2021 Form 4 Insider Report for Ampio Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Daniel Stokely, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
30 Dec 2021
Net transactions value
$0
Form type
4
Filing time
03 Jan 2022, 19:10:27 UTC
Previous filing
15 Oct 2021
Next filing
12 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPE Stock Option (Right to Buy) Award $0 +75,000 $0.000000 75,000 30 Dec 2021 Common Stock 75,000 $0.5600 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest 1/12 monthly on the 30th of each month for one year (until December 30, 2022).